Stock data
CAMP4 Therapeutics Corporation (CAMP)
CAMP4 Therapeutics Corporation (CAMP) reported revenue of US$3.50M and net income of -US$80.40M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$3.50M | — | -US$52.55M | -US$80.40M | — |
| 2024 | US$0.65M | — | -US$53.09M | -US$51.79M | — |
| 2023 | US$0.35M | — | -US$51.88M | -US$49.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.78M | -US$33.53M | — |
| 2026-03-31 | US$1.29M | -US$18.33M | — |
| 2025-12-31 | US$0.35M | -US$40.28M | — |
| 2025-09-30 | US$0.80M | -US$15.10M | — |
| 2025-06-30 | US$1.50M | -US$12.59M | — |
| 2025-03-31 | US$0.86M | -US$12.43M | — |
| 2024-12-31 | US$0.65M | -US$13.28M | — |
| 2024-09-30 | US$0.00M | -US$13.48M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.